Case studies
See how life sciences teams use Prognos lab data, HCP alerts, patient finding, Care Team enrichment, and harmonization to act on clinically meaningful signals.
Browse the library
How Care Team enrichment expanded one patient’s provider view beyond the ordering HCP, adding specialty and activity context.
How lab results and medical history flagged potential Gaucher patients and supported weekly physician follow-up.
How a rare disease biotech linked mutation carriers with progression signals and their treating physicians for trial outreach.
How source-specific interpretation completed units, reference ranges, and abnormal flags around existing ALT and AST results.
How a pharmaceutical company evaluated lab-based patient finding for a rare disease launch—and found greater provider relevance.
How timely lab-based HCP alerts and treating-oncologist identification supported engagement during a narrow treatment-decision window.
How clean lab data, frequent alerts, and treating-oncologist enrichment supported a biopharmaceutical company’s oncology field teams.
How lab-based HCP alerts helped focus engagement and sustain investment through restructuring and tighter budgets.
How timely, consistent lab-based HCP alerts supported commercialization of a therapy for Lambert-Eaton myasthenic syndrome.
No case studies match this filter yet.
Talk with Prognos about the tests, patient populations, and provider context that matter for your program.